Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Ruder Finn

    Healthcare setting

    Clinical research in 2026: The trends shaping tomorrow

    Discover the key trends shaping clinical research in 2026, from patient-centric approaches to empowering site staff and fostering stronger human connections.

    Cuttsy + Cuttsy

    - PMLiVE

    Novartis’ Itvisma gets FDA approval for spinal muscular atrophy treatment

    Around 9,000 people in the US currently live with SMA

    - PMLiVE

    Novartis announces plans for new US manufacturing hub

    The US hub is expected to create 700 new jobs by 2030

    - PMLiVE

    Novartis reports primary endpoint reached in phase 3 malaria trial

    The treatment demonstrated non-inferiority to current standard of care

    - PMLiVE

    Novartis presents new positive data for rheumatic autoimmune disease treatment

    Patient outcome benefits were observed in two ongoing phase 3 trials

    - PMLiVE

    Novartis to acquire Avidity Biosciences in deal worth $12bn

    The acquisition will expand Novartis’ neuroscience pipeline

    - PMLiVE

    Minds + Assembly Launches Assembled Intelligence and Adds Stratevi to Expand Market Access and HEOR Solutions

    New York, NY — 10.23.2025 — Minds + Assembly, a leading healthcare marketing firm, today announced the launch of Assembled Intelligence, an integrated communications and commercialization platform designed to unite...

    BOLDSCIENCE

    - PMLiVE

    Novartis announces new data supporting MS therapy Kesimpta

    The latest trial results reinforce the drug's long-term efficacy and safety profile

    Epilepsy meds app silver award at PMi Awards

    Genetic Digital Wins Silver at PM Society Digital Awards for Epilepsy Meds Clinical Support App

    Genetic Digital wins Silver at the PM Society Digital Awards for Epilepsy Meds, a clinical support app developed with Desitin and ChangeMed to aid patient-specific prescribing in epilepsy care.

    Genetic Digital

    - PMLiVE

    Novartis to acquire Tourmaline Bio in a deal worth $1.4bn

    Novartis will gain cardiovascular treatment option pacibekitug

    - PMLiVE

    Digital Touchpoints That Work for Pharma

    Creative and compliant ways to enhance your exhibition presence.

    Apex Events and Exhibitions

    - PMLiVE

    Novartis’ ianalumab shows promise in phase 3 Sjögren’s syndrome studies

    The systemic autoimmune disease affects approximately 0.6% of the UK’s adult population

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links